Exact Sciences Corp (NAS:EXAS)
$ 53.52 2.52 (4.94%) Market Cap: 9.88 Bil Enterprise Value: 11.78 Bil PE Ratio: 0 PB Ratio: 3.14 GF Score: 78/100

Exact Sciences Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 07:50PM GMT
Release Date Price: $145.37 (-2.05%)
Eleni Maria Apostolatos
JPMorgan Chase & Co, Research Division - Research Analyst

Good afternoon, everyone. My name is Eleni, and I am on Tycho's life science team. It is my pleasure today to introduce our next company, Exact Sciences. We have CEO, Kevin Conroy, joining us today. As a reminder, you can submit questions through the Ask a Question feature on the event [debut] on the website, and we will get to them in the Q&A at the end of the presentation.

And with that, I'll hand it over to Kevin.

Kevin T. Conroy
Exact Sciences Corporation - Chairman of the Board, President & CEO

Thank you, and thanks to all of you for joining us and to JPMorgan for having us back. Against the backdrop of a challenging year caused by COVID-19, our team's execution puts us in a position to help even more patients now and in the future. This comes at a time when there's a new recognition and an appreciation for the power of cancer diagnostics. The focus is clearly shifting in oncology to earlier detection and smarter answers through tests that help guide

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot